Seabrook Partner, Cepheid at Front Line of Covid19 Battle

Seabrook Partner, Cepheid at Front Line of Covid19 Battle

by | Mar 31, 2020 | News

From medicaldevice-network.com: Cepheid has received emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its rapid molecular diagnostic test, Xpert Xpress SARS-CoV-2. The test is designed for the qualitative detection of SARS-CoV-2...